Close Menu

Lung Cancer

News and reporting on lung cancer.

MDRNA also reported its fourth-quarter financial results, posting lower operating costs on the elimination of non-RNAi programs and operations the company was working on prior to a corporate reorganization.

Med BioGene's CEO said the company is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a CLIA-compliant partner lab.

The expanded deal will provide Med Biogene with additional markers for its LungExpress Dx test.

Strands: Mar 12, 2009

Premium

Rosetta Genomics, Alnylam Pharmaceuticals, Massachusetts Institute of Technology

In opening its new translational research lab, Mass General claims to be "the first and only cancer center" to attempt to molecularly profile all cancer patients that present to the facility.

Snippets: Mar 11, 2009

Premium

Chronix Biomedical, Rosetta Genomics, National Institute of General Medical Sciences, National Center for Genome Resources, Beyond Batten Disease Research Foundation, and more ...

People Transfer: Mar 11, 2009

Premium

ASU Biodesign Institute names Alan Nelson as institute director, and Joshua LaBaer as head of institute's Piper Center for Personalized Diagnostics

During the firm's earnings call last week, CEO Amit Kumar said that the company's diagnostics services performance would be most indicative of how CombiMatrix would perform going forward.

Papers of Note: Mar 10, 2009

Premium

Sequencing-Related Papers of Note, Feb. 2009

The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.